• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 COVID-19 中吸取的教训,以促进未来的证据综合工作:第一个实时搜索策略和过时的科学出版和索引行业(已提交)。

Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry (submitted).

机构信息

Information Scientist, Cochrane Schizophrenia Group, Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK; Institute of Mental Health, A Partnership Between the University of Nottingham and Nottinghamshire Healthcare NHS Trust, Nottingham, UK.

Goldsmiths, University of London, London, UK.

出版信息

J Clin Epidemiol. 2020 Jul;123:171-173. doi: 10.1016/j.jclinepi.2020.04.014. Epub 2020 Apr 27.

DOI:10.1016/j.jclinepi.2020.04.014
PMID:32376119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7184009/
Abstract

• The guidance on excluding non-English literature in evidence synthesis may not be suitable for topics where studies are likely to be from a non-English geography. • The routine practice of developing search strategies may not fit the rapidly changing concepts such as COVID-19 and we need living search strategies. • Out-of-date publishing and indexing policies need to be updated.

摘要

• 在证据综合中排除非英语文献的指导意见可能不适用于那些研究很可能来自非英语地区的主题。 • 开发搜索策略的常规做法可能不适合像 COVID-19 这样快速变化的概念,我们需要实时搜索策略。 • 需要更新过时的出版和索引政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2c/7184009/942e45b6a46d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2c/7184009/942e45b6a46d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2c/7184009/942e45b6a46d/gr1_lrg.jpg

相似文献

1
Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry (submitted).从 COVID-19 中吸取的教训,以促进未来的证据综合工作:第一个实时搜索策略和过时的科学出版和索引行业(已提交)。
J Clin Epidemiol. 2020 Jul;123:171-173. doi: 10.1016/j.jclinepi.2020.04.014. Epub 2020 Apr 27.
2
Reply to letter to the editor "Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry".致编辑信件的回复:“COVID-19给未来证据综合工作带来的教训:首个实时检索策略以及过时的科学出版与索引行业”
J Clin Epidemiol. 2020 Jul;123:173-174. doi: 10.1016/j.jclinepi.2020.04.013. Epub 2020 Apr 20.
3
Challenges to scientific publishing in times of COVID-19.新冠疫情时期科学出版面临的挑战。
J R Coll Physicians Edinb. 2020 Jun;50(2):207-214. doi: 10.4997/JRCPE.2020.235.
4
The Role of Scientific Publishing in the SARS-CoV-2 Pandemic.科学出版在新冠疫情中的作用
Pharmacotherapy. 2020 May;40(5):376-378. doi: 10.1002/phar.2402. Epub 2020 May 4.
5
Rapid publishing in the era of coronavirus disease 2019 (COVID-19).2019冠状病毒病(COVID-19)时代的快速出版
Med J Aust. 2020 Jun;212(11):535-536. doi: 10.5694/mja2.50625. Epub 2020 May 31.
6
In search of the relevant COVID research.寻找相关的新冠病毒研究。
Eur J Public Health. 2020 Oct 1;30(5):850-851. doi: 10.1093/eurpub/ckaa169.
7
Publishing research during pandemics: are you vulnerable to the COVID-19 or predatory publishers?在疫情期间发表研究成果:你会受到新冠疫情相关出版商或掠夺性出版商的影响吗?
J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S166-S168. doi: 10.5455/JPMA.39.
8
The first 10 000 COVID-19 papers in perspective: are we publishing what we should be publishing?透视首批10000篇新冠病毒肺炎相关论文:我们发表的是我们应该发表的内容吗?
Eur J Public Health. 2020 Oct 1;30(5):849-850. doi: 10.1093/eurpub/ckaa170.
9
Publishing in face of the COVID-19 pandemic.在新冠疫情期间发表文章。
Int J Antimicrob Agents. 2020 Jul;56(1):106081. doi: 10.1016/j.ijantimicag.2020.106081. Epub 2020 Jul 13.
10
The importance of publishing non-COVID-19 research during COVID-19.在新冠疫情期间发表非新冠病毒研究的重要性。
J Clin Epidemiol. 2020 Oct;126:192. doi: 10.1016/j.jclinepi.2020.06.038. Epub 2020 Jul 3.

引用本文的文献

1
Preprint pointers from a long COVID scoping review: considerations for source selection and searching.一篇关于长期新冠的范围综述中的预印本提示:来源选择和检索的注意事项
J Can Health Libr Assoc. 2024 Aug 1;45(2):88-97. doi: 10.29173/jchla29741. eCollection 2024 Aug.
2
A living critical interpretive synthesis to yield a framework on the production and dissemination of living evidence syntheses for decision-making.一项关于生成和传播用于决策的活证据综合的框架的生活关键解释性综合。
Implement Sci. 2024 Sep 27;19(1):67. doi: 10.1186/s13012-024-01396-2.
3
The NICE search filters for treating and managing COVID-19: validation in MEDLINE and Embase (Ovid).

本文引用的文献

1
Keeping up with studies on covid-19: systematic search strategies and resources.紧跟新冠病毒相关研究:系统检索策略与资源
BMJ. 2020 Apr 23;369:m1601. doi: 10.1136/bmj.m1601.
2
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
3
Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study.
用于治疗和管理 COVID-19 的 NICE 搜索筛选器:在 MEDLINE 和 Embase(Ovid)中的验证。
J Med Libr Assoc. 2024 Jul 1;112(3):225-237. doi: 10.5195/jmla.2024.1806. Epub 2024 Jul 29.
4
Ten principles for generating accessible and useable COVID-19 environmental science and a fit-for-purpose evidence base.生成可获取且可用的新冠疫情环境科学及适用证据库的十条原则。
Ecol Solut Evid. 2021 Jan-Mar;2(1):e12041. doi: 10.1002/2688-8319.12041. Epub 2021 Feb 4.
5
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review.瑞德西韦治疗 COVID-19 的成本效益及成本与资源使用证据:系统评价。
Infection. 2023 Apr;51(2):285-303. doi: 10.1007/s15010-022-01930-8. Epub 2022 Oct 12.
6
Multi-probe attention neural network for COVID-19 semantic indexing.多探针注意力神经网络用于 COVID-19 语义索引。
BMC Bioinformatics. 2022 Jun 29;23(1):259. doi: 10.1186/s12859-022-04803-x.
7
COVID 19 Scoping: A Systemic Review and Meta-Analysis.新型冠状病毒肺炎的范围界定:一项系统评价与荟萃分析。
J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S938-S942. doi: 10.4103/jpbs.jpbs_387_21. Epub 2021 Nov 10.
8
Methodological assessment of systematic reviews and meta-analyses on COVID-19: A meta-epidemiological study.方法学评估系统评价和荟萃分析 COVID-19:一项荟萃流行病学研究。
J Eval Clin Pract. 2021 Oct;27(5):1123-1133. doi: 10.1111/jep.13578. Epub 2021 May 5.
9
COVID-19 meta-analyses: a scoping review and quality assessment.COVID-19 荟萃分析:范围综述和质量评估。
Einstein (Sao Paulo). 2021 Mar 15;19:eAO6002. doi: 10.31744/einstein_journal/2021AO6002. eCollection 2021.
10
The mass production of systematic reviews about COVID-19: An analysis of PROSPERO records.大规模生产关于 COVID-19 的系统评价:PROSPERO 记录分析。
J Evid Based Med. 2021 Feb;14(1):56-64. doi: 10.1111/jebm.12426. Epub 2021 Feb 17.
排除非英语文献对证据综合没有改变结论:一项meta 流行病学研究。
J Clin Epidemiol. 2020 Feb;118:42-54. doi: 10.1016/j.jclinepi.2019.10.011. Epub 2019 Nov 4.